• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS W/SA 20 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV SYS W/SA 20 A.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV434-T
Device Problems Mechanical Problem (1384); Infusion or Flow Problem (2964)
Patient Problem Patient Problem/Medical Problem (2688)
Event Type  Injury  
Manufacturer Narrative
When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported the leakage occurred.The reporter indicated that on (b)(6) 2019, it was found that during a intraoperative procedure that the surgeon noticed obvious cerebrospinal fluid leakage at the silica gel connection between the adjustable pressure valve and the gravity valve.All the doctors and nurses who touch the shunt operated according to the standard procedure and did not touch any sharp tools.Additional event details have not been provided.A request for additional information has been made, however, not yet received.
 
Manufacturer Narrative
Investigation: visual inspection: in the first step of our investigations, we carried out a visual test on the shunt system.Permeability test: to prove the penetrability of the shunt system we have carried out penetrability test.This test is carried out at a hydrostatic pressure of approximately 20-30 cmh2o in the direction of flow.This test is not applicable, because the missing release of investigation.Adjustment test: our adjustment tests are carried out with the standard progav checkmate and measurement tool.The valve is adjusted from 0 to 20 cmh2o and down again in increments of 5 cmh2o.This test is not applicable, because the missing release of investigation.Braking force and brake function test: to measure the braking force, we tested the progav valve with a braking force device.Here it is measured how much force must be exerted on the housing to release the rotor to adjust the valve by the integrated magnet of the braking force device.This test is not applicable, because the missing release of investigation.Results: the visual investigation indicated no damage to the catheter or the other components.There were visible crystalline deposits on the product.Further investigations are not applicable due to the lack of release for investigation.Based on our visual investigation, we are unable to substantiate a leakage between the valves.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV SYS W/SA 20 A.CONTROL RESERVOIR
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9384790
MDR Text Key184884885
Report Number3004721439-2019-00283
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/29/2024
Device Model NumberFV434-T
Device Catalogue NumberFV434-T
Device Lot Number20040985
Was Device Available for Evaluation? No
Date Manufacturer Received01/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-